8-K: Vireo Acquires Schwazze Convertible Notes at Discount

Vireo Growth Inc. announced it will acquire approximately $2.6 million of Schwazze's defaulted senior secured convertible notes for $1.6 million in Vireo shares, increasing its ownership to 89%.

Summary

• Vireo Growth Inc. is acquiring additional 13% Senior Secured Convertible Notes due December 7, 2026, from Medicine Man Technologies, Inc. d/b/a Schwazze.
• The Notes have a total value of approximately $2,600,000, including principal and accrued interest.
• Vireo will acquire these Notes for a total consideration of approximately $1,600,000.
• The consideration will be paid in Vireo's subordinate voting shares at a deemed price of $0.54 per share.
• This acquisition will increase Vireo's ownership of the total outstanding Notes to approximately 89%.
• The transaction is expected to close by December 31, 2025, pending approval by the Canadian Stock Exchange.
• Schwazze is currently in default on its payment obligations under these Notes.
• The Notes are secured by various assets of Schwazze and its subsidiaries.

Sentiment

Score: 7

Explanation: The acquisition of defaulted debt at a significant discount is a positive strategic move, potentially allowing Vireo to gain control or influence over Schwazze's assets or future. However, the underlying default of Schwazze and the related-party nature introduce some caution.

Positives

• Vireo is acquiring $2,600,000 worth of notes for a significant discount, paying only $1,600,000, representing a 38.5% discount to par value plus accrued interest.
• The acquisition increases Vireo's ownership of the outstanding Schwazze notes to approximately 89%, giving it substantial control over the debt.
• The consideration is paid in Vireo's subordinate voting shares, conserving cash.

Negatives

• Schwazze, the issuer of the notes, is currently in default on its payment obligations.
• The transaction involves a related party, as Vireo's CEO, John Mazarakis, is a partner in an affiliate of the collateral agent for the Notes.

Risks

• Risks related to the timing and content of adult-use legislation in markets where the Company currently operates.
• Current and future market conditions, including the market price of Vireo's subordinate voting shares.
• Risks related to epidemics and pandemics.
• Federal, state, local, and foreign government laws, rules, and regulations, including those relating to cannabis operations in the United States.
• Operational, regulatory, and other risks inherent in the business.
• Challenges in the execution of business strategy and management of growth.
• Difficulties inherent in forecasting future events.
• Conflicts of interest, particularly given the related-party transaction.
• Risks inherent in an agricultural business and a manufacturing business.
• Liquidity and the Company's ability to raise additional financing to continue as a going concern.
• The Company's ability to meet the demand for flower in its various markets.
• Risk of failure in the lawsuit with Verano and the cost of that litigation.
• Ability to dispose of assets held for sale at an acceptable price or at all.

Future Outlook

The Company expects the acquisition of the Notes to close by December 31, 2025, subject to Canadian Stock Exchange approval. General forward-looking statements include expectations around future M&A strategy, optimization of business areas, and benefits from expansion into the adult-use cannabis market, including expected future revenues and growth.

Management Comments

• "Vireo is building a disciplined, strategically aligned, and execution-focused platform in the industry."
• "This strategy drives our intense local market focus while leveraging the strength of a national portfolio."
• "We are committed to hiring industry leaders and deploying capital and talent where we believe it will drive the most value."
• "Vireo operates with a long-term mindset, a bias for action, and an unapologetic commitment to its customers, employees, shareholders, industry collaborators, and the communities it serves."

Industry Context

This transaction occurs within the evolving U.S. cannabis industry, characterized by ongoing M&A activity, regulatory changes (e.g., adult-use legislation), and financial distress among some operators, as evidenced by Schwazze's default. Vireo's strategy of acquiring distressed debt at a discount could be a way to gain strategic assets or influence in a consolidating market.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess the acquisition against global benchmarks.

Legal Proceedings

• Schwazze is currently in default on its payment obligations under the Notes.
• The Company mentions a "risk of failure in the lawsuit with Verano and the cost of that litigation" in its forward-looking statements, indicating ongoing legal proceedings not directly related to this transaction but a general risk.

Related Party Transactions

• John Mazarakis, Vireo's Chief Executive Officer, is a partner of Chicago Atlantic Group, LP, an affiliate of Chicago Atlantic Admin, LLC, which serves as the collateral agent under the Indenture governing the terms of the Notes being acquired.

Stakeholder Impact

• Shareholders (Vireo): Potential for increased value if the acquired notes lead to favorable outcomes (e.g., asset acquisition, recovery of debt). Dilution from the issuance of new shares as consideration.
• Noteholders (Schwazze): Those selling their notes receive Vireo shares at a discount to the notes' par value plus accrued interest, indicating a loss on their original investment but potentially liquidity.
• Schwazze: The default on its notes indicates financial distress, and Vireo's increased ownership of its debt could influence its future.
• Employees (Vireo): No direct impact mentioned, but strategic moves can affect long-term stability.
• Customers/Suppliers: No direct impact mentioned.

Next Steps

• Closing of the acquisition of the Notes, expected by December 31, 2025.
• Approval by the Canadian Stock Exchange for the transaction.
• Potential future M&A activities as part of the Company's strategy.
• Continued optimization of all areas of the Company's business.
• Expansion into the adult-use cannabis market.

Key Dates

Recommendation

While acquiring defaulted debt at a significant discount is a potentially shrewd strategic move, the underlying default of Schwazze introduces considerable risk. The related-party transaction also warrants close scrutiny. The issuance of shares as consideration will dilute existing shareholders. Investors should hold to observe how Vireo plans to leverage its increased ownership of Schwazze's debt and how the broader cannabis market and regulatory environment evolve, especially given the inherent risks in the industry and the company's liquidity concerns mentioned in the forward-looking statements.

Keywords

Vireo Growth Inc., Schwazze, Convertible Notes, Debt Acquisition, Cannabis Industry, SEC Filing, Form 8-K, Senior Secured Notes, Defaulted Debt, Related Party Transaction, CSE: VREO, OTCQX: VREOF